The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy
Open accessAbstract
A randomized, double-blind trial comparing oral fluconazole (400 mg daily) with placebo as prophylaxis for adult patients receiving intensive cytotoxic therapy for acute leukemia or autologous bone marrow transplantation was conducted in 14 Canadian university-affiliated hospitals. Although fluconazole prophylaxis did not obviate the need for parenteral antifungal therapy compared with placebo (81 [57%] of 141 vs. 67 [50%] of 133, respectively), its use resulted in fewer superficial fungal infections (10 [7%] of 141 vs. 23 [18%] of 131, respectively; P = .02) and fewer definite and probable invasive fungal infections (9 vs. 32, respectively; P = .0001). Fluconazole recipients had fewer deaths attributable to definite invasive fungal infection (1 of 15 vs. 6 of 15, respectively; P = .04) and achieved more frequent success without fungal colonization (52 [37%] of 141 vs. 27 [20%] of 133, respectively; P = .004; relative risk reduction, 85%) than did placebo recipients. Patients benefiting the most from fluconazole prophylaxis included those with acute myeloid leukemia who were undergoing induction therapy with cytarabine plus anthracycline-based regimens and those receiving marrow autografts not supported with hematopoietic growth factors. Fluconazole prophylaxis reduces the incidence of superficial fungal infection and invasive fungal infection and fungal infection-related mortality among patients who are receiving intensive cytotoxic chemotherapy for remission induction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R., Meyers, J. D., & Bowden, R. A. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1545 · Cited by 820
Candida Colonization and Subsequent Infections in Critically III Surgical Patients
Pittet, D., Monod, M., Suter, P. M., Frenk, E., & Auckenthaler, R. (1994) · Annals of Surgery · doi:10.1097/00000658-199412000-00008 · Cited by 798
Fungal infections in cancer patients: An international autopsy survey
Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F., Milliken, S., et al. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967060 · Cited by 547
Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H., Shadduck, R. K., Rosenfeld, C. S., Ho, W. G., Islam, M. Z., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00003 · Cited by 373
Fungal infections in patients with acute leukemia
Degregorio, M. W., Lee, W. M. F., Linker, C. A., Jacobs, R. A., & A. Ries, C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90334-5 · Cited by 354
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E., & Saral, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1847 · Cited by 340
Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever--Reply
Hughes, W. T., Armstrong, D., Bodey, G. P., Feld, R., Mandell, G. L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. C., et al. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.202 · Cited by 319
Bow, E. J., Loewen, R., Cheang, M. S., & Schacter, B. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.361 · Cited by 181
Self-citationGuiot, H. F. L., Fibbe, W. E., & van't Wout, J. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.4.525 · Cited by 179
Menichetti, F., Favero, A. D., Martino, P., Bucaneve, G., Micozzi, A., D'Antonio, D., Ricci, P., Carotenuto, M., Liso, V., Nosari, A. M., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-11-199406010-00003 · Cited by 139
Bodey, G. P., Anaissie, E. J., Elting, L. S., Estey, E. H., O'Brien, S. M., & Kantarjian, H. M. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2099::aid-cncr2820730814>3.0.co;2-n · Cited by 127
Schaffner, A., & Schaffner, M. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.4.1035 · Cited by 120
Wiley, J. M., Smith, N., Leventhal, B. G., Graham, M. L., Strauss, L. C., Hurwitz, C. A., Modlin, J. F., Mellits, D., Baumgardner, R. A., & Corden, B. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.2.280 · Cited by 114
Philpott‐Howard, J., Wade, J. J., Mufti, G. J., Brammer, K. W., & Ehniniger, G. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.6.973 · Cited by 113
Bow, E. J., Loewen, R., Cheang, M., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2254 · Cited by 103
Self-citationEllis, M. E., Clink, H. M., Ernst, P., Halim, M. A., Padmos, A., Spence, D. J., Kalin, M., Qadri, S. M. H., Burnie, J., & Greer, W. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026116 · Cited by 96
Chemotherapy for multiple myeloma
Alexanian, R., & Dreicer, R. (1984) · Cancer · doi:10.1002/1097-0142(19840201)53:3<411::aid-cncr2820530308>3.0.co;2-e · Cited by 90
Rossetti, F., Brawner, D. L., Bowden, R. A., Meyer, W. G., Schoch, H. G., Fisher, L. D., Myerson, D., Hackman, R. C., Shulman, H. M., Sale, G. E., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.801 · Cited by 73
Effect of Fluconazole Prophylaxis on Fever and Use of Amphotericin in Neutropenic Cancer Patients
Chandrasekar, P. H., Gatny, C. M., & Bone Marrow Transplantation Team (2009) · Chemotherapy · doi:10.1159/000239184 · Cited by 50
Response to Empiric Amphotericin B During Antileukemic Therapy-Induced Granulocytopenia
Karp, J. E., Merz, W. G., & Charache, P. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.4.592 · Cited by 50
Palmblad, J. E. W., Lönnqvist, B., Carlsson, B., Grimfors, G., Järnmark, M., Lerner, R., Ljungman, P. T., Nyström-Rosander, C., Petrini, B., & Öberg, G. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00945.x · Cited by 45
Management of Fungal Infection in Neutropenic Patients with Fluconazole
Brammer, K. W. (1990) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-74643-7_97 · Cited by 40
Egger, T., Gratwohl, A. A., Tichelli, A., Uhr, M., Gysi, C. S., Passweg, J. R., Pless, M., Wernli, M., Buser, U., Wuhrmann, J., et al. (1995) · Supportive Care in Cancer · doi:10.1007/bf00365855 · Cited by 39
Flynn, P. M., Shenep, J. L., Crawford, R., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.964 · Cited by 30
Akiyama, H., Mori, S., Tanikawa, S., Sakamaki, H., & ONOZAWA, Y. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00725.x · Cited by 26
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citation2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Waselenko, J. K., MacVittie, T. J., Blakely, W. F., Pesik, N., Wiley, A. L., Dickerson, W. E., Tsu, H., Confer, D. L., Coleman, C. N., Seed, T., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-12-200406150-00015 · Cited by 766
Metadata
- Authors
- Rotstein, C., Bow, E. J., Laverdiere, M., Ioannou, S., Carr, D., Moghaddam, N., & The Canadian Fluconazole Prophylaxis Study Group
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02
- Volume
- 28
- Issue
- 2
- Pages
- 331-340
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2109088397
- Cited by
- 265
- References
- 28
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.